| Authors: |
Kato K; Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Xu RH; Collaborative Innovation Center of Cancer Medicine, Department of Medical Oncology, University Cancer Center State Key Laboratory of Oncology in South China, Guangzhou, China., Oh DY; Department of Internal Medicine, Seoul National University Hospital Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea., Bai Y; Department of Gastrointestinal Oncology, Harbin Medical University Cancer Hospital, Harbin, China., Shi J; Department II of Medical Oncology, Linyi Cancer Hospital, Linyi, China., Lee KW; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea., Hirano H; Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Xu H; Clinical Development, BeOne Medicines, Ltd, Beijing, China., Sheng T; Biostatistics/Clinical Development, BeOne Medicines, Ltd, Beijing, China., B Barnes F; Patient-Reported Outcomes Function, Global Medical Affairs, BeOne Medicines, Ltd, San Carlos, CA, USA., Barnes G; Patient-Reported Outcomes Function, Global Medical Affairs, BeOne Medicines, Ltd, San Carlos, CA, USA. |
